awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55411384-12E104E9-243A-464C-84D5-DCD47FDCCC41
Q55411384-12E104E9-243A-464C-84D5-DCD47FDCCC41
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55411384-12E104E9-243A-464C-84D5-DCD47FDCCC41
SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists.
P2860
Q55411384-12E104E9-243A-464C-84D5-DCD47FDCCC41
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55411384-12E104E9-243A-464C-84D5-DCD47FDCCC41
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6f3b387e6757569e6b30452f01a42677f2e5e622
P2860
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).